| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |